Allergan Targets Sandoz Over Generic Latisse
Allergan Inc. launched a patent infringement suit Friday in a North Carolina federal court over Sandoz Inc.'s efforts to manufacture a generic version of Latisse, a treatment to stimulate eyelash growth....To view the full article, register now.
Already a subscriber? Click here to view full article